Kraig Biocraft Laboratories, Inc., announces it has now taken possession of its new recombinant spider silk production center in Lam Dong Province, Vietnam.
ANN ARBOR, Mich., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces it has now taken possession of its new recombinant spider silk production center in Lam Dong Province, Vietnam. This new facility is located in the heart of Vietnam’s booming silk economy and will serve as the center of operations for the Company’s growing spider silk production in 2024.
The Company selected this facility and is opening this new operations center to support the significant expansion of silk production scheduled for spring 2024.
Securing this new facility is happening in parallel with the Company’s recently announced MOU with the Vietnam Sericulture Association (“VSA”) and Lam Dong Agro-Forestry Research and Experiment Center (“LAREC”).
Kraig Labs expects this center will serve as a central location for collaboration with the VSA and LAREC to enhance sericulture in Vietnam. The Company anticipates this facility will also serve as the distribution and collection hub for the resulting recombinant spider silk fibers, yarns, and fabrics.
The facility is located in the center of Vietnam’s largest silk-producing region, providing excellent access to fresh mulberry, skilled sericulture staffing, and cocoon reeling facilities.
“We are prepared for 2024 to be a breakthrough year for the commercialization of spider silk. Positioning our operations in the heart of Vietnam’s silk manufacturing center is a significant element of that growth,” said CEO and Founder, Kim Thompson. “Our team is now preparing for the spring production trials and the launch of our new BAM 1 hybrid. We expect to have this new facility online to support these exciting milestones and the commercialization of our cost-effective, eco-friendly spider silk.”
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of recombinant spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward-Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
